Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 1385.02x is 96% above its estimated 1-year average of 707.52x, near the high end of its estimated 1-year range (645.96x–1386.04x).
As of 2026-10-06T15:27:54.255Z.
Calculation as of: 2026-10-06T15:27:54.255Z.
Quote observation: 2026-10-06T15:25:36.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 82cee4a6010f8650e239c44e6fa86f6cad5a1cacb0b867e980d6d40a64789328
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
1385.02x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.15x
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
+33273.98%
vs the sector median at left
Nautilus Biotechnolgy, Inc.
Market Cap
$248.50M
EV/Sales Ratio
1385.02x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$244.71M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.62M
EV/Sales Ratio
N/A
TTM Avg
2.84x
3Y Avg
2.61x
5Y Avg
2.12x
Market Cap
$243.50M
EV/Sales Ratio
0.65x
TTM Avg
1.18x
3Y Avg
2.00x
5Y Avg
1.54x
Market Cap
$242.35M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.30M
EV/Sales Ratio
N/A
TTM Avg
1627.36x
3Y Avg
1007.98x
5Y Avg
1007.98x
Market Cap
$256.22M
EV/Sales Ratio
N/A
TTM Avg
0.88x
3Y Avg
37.95x
5Y Avg
73.84x
Market Cap
$257.22M
EV/Sales Ratio
2.01x
TTM Avg
1.60x
3Y Avg
1.66x
5Y Avg
1.91x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nautilus Biotechnolgy, Inc. (NAUT) | $248.50M | 1385.02x | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $248.06M | 1.65x | 3.13x | 2.68x | 2.68x |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $244.71M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A | 2.84x | 2.61x | 2.12x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $243.50M | 0.65x | 1.18x | 2.00x | 1.54x |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | N/A | N/A | N/A | N/A |
| InflaRx N.V. (IFRX)vs › | $242.30M | N/A | 1627.36x | 1007.98x | 1007.98x |
| Century Therapeutics, Inc. (IPSC)vs › | $256.22M | N/A | 0.88x | 37.95x | 73.84x |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.22M | 2.01x | 1.60x | 1.66x | 1.91x |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.72M | 36.76x | 25.87x | 23.90x | 23.90x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 1325.94x |
| 2026-10-02 | 1386.04x |
| 2026-10-01 | 1125.59x |
| 2026-09-30 | 1025.42x |
| 2026-09-29 | 992.02x |
| 2026-09-28 | 818.39x |
| 2026-09-25 | 720.02x |
| 2026-09-24 | 738.59x |
| 2026-09-23 | 714.14x |
| 2026-09-22 | 744.53x |
| 2026-09-21 | 714.68x |
| 2026-09-18 | 722.22x |
| 2026-09-17 | 726.03x |
| 2026-09-16 | 726.30x |
| 2026-09-15 | 672.20x |
| 2026-09-14 | 682.35x |
| 2026-09-11 | 758.29x |
| 2026-09-10 | 737.98x |
| 2026-09-09 | 825.07x |
| 2026-09-08 | 696.78x |
| 2026-09-04 | 681.42x |
| 2026-09-03 | 691.17x |
| 2026-09-02 | 719.42x |
| 2026-09-01 | 695.84x |
| 2026-08-31 | 726.50x |
| 2026-08-28 | 668.60x |
| 2026-08-27 | 680.89x |
| 2026-08-26 | 703.12x |
| 2026-08-25 | 665.66x |
| 2026-08-24 | 661.65x |
| 2026-08-21 | 714.54x |
| 2026-08-20 | 679.68x |
| 2026-08-19 | 679.15x |
| 2026-08-18 | 645.96x |
| 2026-08-17 | 665.12x |
| 2026-08-14 | 672.80x |
| 2026-08-13 | 671.47x |
| 2026-08-12 | 677.95x |
| 2026-08-11 | 672.00x |
| 2026-08-10 | 654.77x |
| 2026-08-07 | 678.21x |
| 2026-08-06 | 668.86x |
| 2026-08-05 | 698.18x |
| 2026-08-04 | 735.11x |
| 2026-08-03 | 751.61x |
| 2026-07-31 | 729.57x |
| 2026-07-30 | 764.96x |
| 2026-07-29 | 771.64x |
